The transcription factor NF-κB and human disease

Journal of Clinical Investigation

Volumn 107, Issue 1, 2001, Pages 3-6

  Baldwin A S , Jr ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

CANCER; DROSOPHILA; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; ANIMAL; APOPTOSIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS; METABOLISM; PHYSIOLOGY; VIRUS REPLICATION;

ANIMALS; APOPTOSIS; GENE EXPRESSION REGULATION; HIV; HUMANS; INFLAMMATION; NF-KAPPA B; VIRUS REPLICATION;

EID: 0035174615     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/jci11891     Document Type: Review

References (41)

1. Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a post-translational mechanism
2. The NF-κB and IκB proteins: New discoveries and insights
3. NF-κB and Rel proteins: Evolutionarily conserved mediators of the immune response
4. Phosphorylation meets ubiquitination: The control of NF-κB activity
5. Embryonic lethality and liver degeneration in mice lacking the Re1A component of NF-κB
6. Requirement for NF-κB in osteoclast and B-cell development
7. Osteopetrosis in mice lacking NF-κB1 and NF-κB2
8. Activation of transcription factor NF-κB in human inflamed synovial tissue
9. NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint
10. Local administration of antisense phosphorothioate oligonucleotides to the RelA subunit of NF-κB abrogates established experimental colitis
11. NF-κB: A pivotal transcription factor in chronic inflammatory disease
12. A potential role of activased NF-κB in the pathogenesis of euthyroid sick syndrome
13. NF-κB-induced post-transcriptional loss of MyoD mRNA: Possible role in muscle decay and cachexia
14. The anti-inflammatory agents aspirin and salicylate inhibit the activity of the IκB kinase β
15. Sulindac inhibits the activation of the NF-κB pathway
16. Sulfasalazine: A potent and specific inhibitor of NF-κB
17. Glucocorticoids repress NF-κB-driven genes by disturbing the interaction of p65 with the basal machinery, irrespective of co-activator levels in the cell
18. Anti-rheumatic compound aurothioglucose inhibits TNFα-induced HIV-1 replication in latently infected OM10.1 and Ach2 cells
19. Oxidized LDL binding to ox-LDL receptor 1 in endothelial cells induces the activation of NF-κB through an increased production of intracellular reactive oxygen species
20. NF-κB functionally interacts with the PDGF B chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress
21. Atherosclerosis: Basic mechanisms. Oxidation, inflammation and genetics
22. Expression of a constitutive NF-κB-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells
23. Activated transcription factor NF-κB is present in the atherosclerotic lesion
24. Chemopreventive properties of trans-resveratrol are associated with inhibition of the IκB kinase
25. Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes
26. Nuclear IκBβ maintains persistent NF-κB activation in HIV-1 infected myeloid cells
27. The role of Rel/NF-κB proteins in viral oncogenesis and the regulation of viral transcription
28. Herpes simplex type 1 induction of persistent NF-κB nuclear translocation increases the efficiency of virus replication
29. Expression of LMP1 in epithelial cells leads to activation of a select subset of NF-κB/Rel family proteins
30. EBV transforming protein LMP1 activates NF-κB through a pathway that includes NIK and IKKα and IKKβ
31. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
32. Control of apoptosis by Rel/NF-κB transcription factors
33. Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-κB
34. NF-κB is activated and promotes cell death in focal cerebral ischemia
35. Characterization of a neuronal κB-binding factor distinct from NF-κB
36. Aberrant Rel/NF-κB genes and activity in human cancer
37. Persistent activation of NF-κB by the Tax transforming protein of HTLV-1: Hijacking cellular IκB kinases
38. Epstein-Barr virus transformation: Involvement of latent membrane protein 1-mediated activation of NF-κB
39. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras
40. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
41. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB